Imiquimod (IMQ)-induced mouse psoriatic model is one of the useful models displaying most of psoriatic features. To compare the modeling efficacy of different IMQ creams, we induced the psoriatic models by topically applying two different brands of IMQ 5% creams to the shaved Balb/c mice skin and assessed the results. Balb/c female mice (n ¼ 24) 8-12 weeks of age were randomly divided into experimental groups A (Likejie), B (Aldara), and control group C (Vaseline); Likejie, Aldara, or Vaseline was topically applied to the back skin for mice in groups A, B, and C, respectively, for six consecutive days. The total psoriasis area and severity index scores of groups A, B, and C were 3.25 AE 1.56, 9.81 AE 0.84, and 0, respectively; the Baker's scores were 2.93 AE 1.07, 6.47 AE 1.50, and 0, respectively; and the epidermis thickness was 49. 79 AE 14.16, 85.62 AE 17.55, and 20 .04 AE 3.68 mm, respectively. The differences between the three groups in dual were statistically significant (P < 0.005 for the groups in dual). Aldara group showed more characteristic alterations of psoriasiform lesions than that of Likejie both macroscopically and histopathologically. The results suggested that different brands of IMQ creams may result in differential efficacy when performing the IMQ-induced psoriasis mouse models.
Introduction
Psoriasis is a common, chronic inflammatory skin disease affecting nearly 2-3% of the world's population. 1 It always involves the skin, and sometimes associates with arthritis, and largely, lowers quality of life. Increasing evidence suggests that psoriasis may be associated with cardiovascular diseases [2] [3] [4] and metabolic syndromes. 5, 6 Although much evidence supports the assertion that psoriasis is a T-cellmediated chronic inflammatory skin disease, its exact pathogenesis is not yet fully understood. 7 The lack of an ideal animal model has greatly hindered study of the etio-pathogenesis of psoriasis. 7 Over the past two decades, various animal models have been built including the spontaneous mouse model, the genetically engineered mouse model, the xenograft model, and the artificial induced model in addition to many others. 7, 8 Despite each model having limitations, these models make the study of psoriasis in vitro possible to some extent. Imiquimod (IMQ) 5% cream, a ligand for TLR7 and TLR8 and a potent immune activator, has been reported to cause psoriasis-like disease in some patients or to exacerbate the lesions in patients with well-controlled psoriasis during topical treatment for other diseases. 9 Daily topical application of IMQ on mouse back skin, including Aldara or other brands of IMQ cream, has been reported to cause inflamed scaly cutaneous lesions mimicking psoriasis. 8, [10] [11] [12] [13] [14] [15] [16] [17] [18] The aim of the present study was to compare the differential effects of IMQ-induced psoriatic mouse models by different brands of IMQ cream.
Materials and methods
Animal experiment BALB/C female mice 8-12 weeks of age obtained from the Laboratory Animal Center (Sun Yat-sen University, China) were used in this experiment. Aldara cream (5% IMQ, 3M Pharmaceuticals, UK) and Likejie cream (5% IMQ, Keyi Pharmaceutic Co. Ltd, Hubei, China) were used to induce the psoriatic models, and Vaseline cream (Hengjian Pharmaceutic Co. Ltd, Guangdong, China) was used as a control. Aldara, Likejie, and Vaseline creams were purchased from a pharmacy.
Mice (n ¼ 24) were randomly divided into experimental group A (Likejie cream), experimental group B (Aldara cream), and the control group C (Vaseline cream) by means of a random number table (eight mice in each group). An area about 2 cm Â 3 cm in size was shaven on the back of each mouse with an electric shaver, and the remaining hairs were completely removed with depilatory cream (Veet TM , Reckitt Benckiser, Cedex, France) before the experiment. The method described by Van der Fits et al. 8 was used for inducing the psoriatic mouse model. Both Likejie and Aldara creams were topically applied to the back skin for six consecutive days at a daily dose of 80 mg (contained 4 mg of the active compound, IMQ) in the experimental groups A and B, respectively. This dosage was determined in our previous study and could cause optimal and reproducible skin inflammation in mice. The control group was treated daily with 80 mg white Vaseline cream on the shaven skin. The day before cream usage was defined as Day 1 and the baselines of every index were evaluated on this day; 24 h after the first application of the cream was defined as Day 2. The mice were sacrificed on Day 7 by cervical dislocation.
Modified psoriasis area and severity index (PASI) score
Based on the clinical PASI score, the scoring system described by Van der Fits et al. 8 was used to evaluate the severity of skin inflammation in the present study. The indexes included erythema, scales, and thickening. Each index was scored independently on a scale from 0 to 4: 0-none, 1-slight, 2-moderate, 3-marked, 4-maximum, and recorded every 24 h. The total score (erythema plus scaling plus thickening) was used to measure the severity of inflammation (scale 0-12). The area score was not taken into account, because each mouse had the same experimental area.
Pathological score
After the mouse was sacrificed, the tested skin was excised immediately and was fixed in 10% formaldehyde for 24 h. The formalin fixed skin tissue was then embedded in paraffin and sectioned vertically at 3 mm. Following this, the section was stained with Harris' hematoxylin and eosin for histological analysis. The Baker's scoring system 19 ( Table 1 ) was used to evaluate the pathological alterations on a scale ranging from 0 to 10. All the sections were scored blindly by two independent investigators and the mean score was recorded.
Measurement of the epidermic thickness
The thickness of the vertical epidermis for each mouse was evaluated under a microscope on three different fields under 100 Â high power; then, the mean thickness was calculated. To evaluate the thickness, the thickest areas with typical psoriatic pathological alterations were selected for groups A and B, and the thickest areas were selected for group C.
Ethics statement
The experiments were approved by the Committee on the Ethics of Animal Experiments of The First Affiliated Hospital, Sun Yat-sen University and were conducted in compliance with the guidelines of China Council on Animal Care and Use. All mice were bred and maintained under specific pathogen-free conditions with sufficient fresh food and water ad libitum. During the experiment, the mice were monitored daily. After experimental completion, mice were sacrificed by cervical dislocation.
Statistical analysis
The statistical software package SPSS 13.0 (SPSS Inc., Chicago, IL, USA) was used for data analyses. Baker's scores (non-parametric distribution) were presented by median (M) and interquartile range (IQR), and Kruskal-Wallis test was used for analysis among the three groups. The total Baker's scores and modified PASI scores were expressed as mean AE standard deviation (means AE SD), respectively, and T test was used to analyze the difference between group A and group B. The epidermic thickness was expressed as mean AE standard deviation (means AE SD), one-way ANOVA was used for analyzing the differences among the three groups, and Bonferroni test was used for multiple comparisons. The Z or t value between group A and group B was expressed as Z A-B or t A-B , and between group B and the control group and group A and the control group as Z B-C , t B-C , Z A-C , t A-C , respectively. A significant p value was set at 0.05 (two-sided).
Results
Skin changes after topically applying of creams Group A. Psoriasiform lesions had formed after topically applying Likejie for six days, showing redness, thickened skin, and scaling. The skin changes on Day 1, 3, 5, and 7 are shown in Figure 1 (a) to (d). Generally, erythema appeared on Day 2 and reached its peak on Day 3, then decreased gradually for the remaining four days, except one mouse showed increasing erythema from Day 3 until Day 7. The scaling started from Day 2 to Day 4 and then decreased until the end of the experiment. The skin revealed increasing thickening from Day 2 to Day 4; after this, the thickening increased mildly up until Day 7.
Group B. All the mice showed typical psoriasis-like lesions after the application of Aldara for six days with evident erythema, scales, and thickened skin. The cutaneous changes on Day 1, 3, 5, and 7 are shown in Figure 1 progressed until Day 7. The scaling started on Day 2 and increased gradually until Day 4 and then progressed rapidly until Day 7. On Day 7, the scaling resembled a mosaic of cobblestones and domed shapes were seen on the skin surface.
Group C. Little cutaneous alterations presented after treatment with Vaseline cream for six days. The modified PASI scores showed that the erythema and skin thickness were more evident in group B than in group A from Day 4 to 7, respectively. The scales formed earlier but regressed more rapidly in group A than in group B (Figure 2 ). The total modified PASI scores were not significantly different between group A and group B in the initial four days, but were statistically significant from Day 5 to 7, with a higher final modified PASI score in group B (9.81 AE 0.84) than in group A (3.25 AE 1.56) (t A-B ¼ 10.478, P < 0.001).
Histopathological alterations after the experiment
Histopathology showed that group A revealed hyperkeratosis and acanthosis, as well as moderate lymphocytic infiltrate and mild angiotelectasis in the dermis; the granular layer was still present and muro abscess was absent (Figure 3(a) ). Group B revealed severe acanthosis, parakeratosis, and moderate rete ridge formation, accompanied by focal munro/kogoj abscess and disappearance of the granular layer, with more evident lymphocytic infiltrate and angiotelectasis in the dermis than group A (Figure 3(b) ). Group C displayed normal dermis as well as epidermis (Figure 3(c) ). The differences of Baker's scores among the three groups ( Table 2 ) were statistically significant (H ¼ 20.096, p < 0.001). Both group A (M: 2.75; IQR: 1.56) and group B (M: 6.75; IQR: 2.63) had higher total Baker's scores than group C (M: 0; IQR: 0.5), respectively (Z A-C ¼ 3.422, P ¼ 0.001; Z B-C ¼ 3.424, P ¼ 0.001, respectively); additionally, the score in group B (6.47 AE 1.50) was much higher than in group A (2.93 AE 1.07) (t A-B ¼ 5.420, P < 0.001).
Epidermis thickness in different groups
The thickness of epidermis for groups A, B, and C was 49.79 AE 14.16, 85.62 AE 17.55, and 20.04 AE 3.68 mm, respectively, with a statistically significant difference (F ¼ 49.600, p < 0.001). The differences among the three groups in dual were also statistically significant (p < 0.005 for three groups in dual). The epidermis of both group A and group B had 3-5 layers of cells while group C had only 1-2 layer(s).
Discussion
It is considered that a perfect psoriasitic animal model should include typical lesions which can be provoked by mild trauma, epidermal hyperproliferation and altered differentiation, papillomatosis, inflammatory cell infiltration including T cells, altered vascularity, and good response to antipsoriatic agents including biological products. 20 Although various kinds of psoriatic models are available at present, no animal model perfectly fulfills the criteria. IMQ-induced mouse model is considered a good model for psoriasis, can easily be obtained, and presents with the typical psoriatic phenotype. 8 It shares most histological features of psoriasis, including cutaneous inflammation, hyperproliferation, and cutaneous infiltration of plasmacytoid dendritic cells CD4 þ T cells, CD11c þ dendritic cells and neutrophils, and even an aberrant antioxidant system. 11, 21 However, the mechanisms for IMQ-induced psoriatic model are not yet fully understood.
The present study showed that both experimental groups presented psoriasis-like lesions after the application of different brands of IMQ cream. The scales in the Likejie group presented earlier with a tendency toward regression during the experiment. However, the Aldara group had higher PASI scores and showed more characteristic lesions and histopathological features including thicker epidermis, the scales presented later than the Likejie group. The results suggested that different brands of IMQ cream can induce the mouse psoriatic-like alterations, but different agents may have differential efficacy when inducing the model. The results also showed that Adala is a more potent inducer compared to Likejie. The reasons for such conditions remain unknown and require further study.
It was reported that the IMQ-induced psoriasis-like cutaneous inflammation in mice was mediated via the IL-23/ IL-17 axis, consistent with human psoriasis. 8, 22, 23 Our previous studies found that Aldara-induced psoriasiform mice had a significant increase of microvessel density in skin lesions, with dilated capillaries in the superficial and middle layers of the dermis 24 and over-expression of cutaneous VEGF predominately distributing the vascular endothelial cells and keratinocytes; although circulating VEGF-A levels showed no significant difference between the experimental and control groups. 25 Walter et al. 26 found that the vehicles in Aldala also play an important role in the modeling process, which can not only induce keratinocyte pyroptosis and parakeratosis, but also upregulate the transcripts for IL-1, G-CSF, S100A8, S100A9, IL-17A, and IL-23 in vivo, even in the absence of IMQ. Isostearic acid, a major component of the vehicles of Aldara, can promote inflammasome activation in cultured keratinocytes. Thus, both IMQ and its vehicles in the Aldara component were considered to be responsible for the psoriatic inflammatory response. However, Likejie is a generic drug and its chemical makeup of vehicles also includes isosteraric acid, but Likejie was a less potent inducer compared to Aldara. We speculated that differential final results for our present study may result from the possibility of the different creams' quality, or somehow inactive IMQ in Likejie, or both. Unfortunately, we cannot find clinical data for a head-to-head comparison between Likejie and Aldara in China showing whether their therapeutic effects have any differences. In the future, an experiment of a head-to-head comparison between Aldara and other IMQ creams such as Likejie may be helpful for us to solve this problem. The present study suggests that different brands of IMQ cream may result in differential results in IMQ-induced psoriatic mouse models. Based on this, researchers should pay attention to the creams' quality when inducing the psoriastic mouse model.
